Long Ideas - Shares of Pain Therapeutics (NASDAQ:PTIE) continue to rise as partner Pfizer (NYSE:PFE) continues to send signals that Remoxy’s New Drug Application (NDA) could be resubmitted … Continue Reading
Read NowLong Ideas - Comments from RW Baird Friday morning point to Merge Healthcare (NASDAQ:MRGE) as a strong stock with near-term value drivers and potential as a take-out candidate. … Continue Reading
Read NowLong Ideas - SciClone Pharmaceuticals (NASDAQ:SCLN) started the day strong, as the company is being cited by dealReporter as exploring strategic options. According to sources, the publication is noting … Continue Reading
Read NowLong Ideas - Halozyme Therapeutics (NASDAQ:HALO) and ViroPharma (NASDAQ:VPHM) announced this morning that the FDA is enabling their subcutaneous version (SC) of Cinryze, a treatment for hereditary angioedema … Continue Reading
Read NowLong Ideas - Synergy Pharmaceuticals (NASDAQ:SGYP) released in an 8-k Thursday night that it has entered into an agreement with Ironwood Pharmaceuticals (NASDAQ:IRWD) for an exclusive worldwide license … Continue Reading
Read NowLong Ideas - A presentation from Idenix Pharmaceuticals (NASDAQ:IDIX) at the UBS Global Life Sciences conference Thursday did little to settle the nerves of IDIX investors who have … Continue Reading
Read NowLong Ideas - Shares of Aeterna Zentaris (NASDAQ:AEZS) are strong Thursday morning after a Buy initiation from Roth Capital with a $1.75 price target, more than double its … Continue Reading
Read Now